1921
Volume 75, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Acute exposure to 2,3,7,8-tetrachlorodibenzo--dioxin (TCDD) can suppress adaptive immunity. In this study, pre-exposure of –infected mice to TCDD caused a dose-dependent and unexpected decrease in parasite burdens on day 20 after infection. In contrast, TCDD-mediated lymphoid atrophy, suppressed antibody levels, and enhanced interleukin-2 production were observed as expected. These results suggest that TCDD may enhance resistance to in the face of immune suppression.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2006.75.749
2006-10-01
2017-11-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/75/4/0750749.html?itemId=/content/journals/10.4269/ajtmh.2006.75.749&mimeType=html&fmt=ahah

References

  1. Lohoff M, Gessner A, Bogdan C, Röllinghoff M, 1998. The Th1/Th2 paradigm and experimental murine leishmaniasis. Int Arch Allergy Immunol 115 : 191–202.
  2. Solbach W, Laskay T, 2000. The host response to Leishmania infection. Adv Immunol 74 : 275–317.
  3. Alexander J, Bryson K, 2005. T helper (h)1/Th2 and Leishmania: Paradox rather than paradigm. Immunol Lett 99 : 17–23.
  4. Brown DR, Reiner SL, 1999. Polarized helper-T-cell responses against Leishmania major in the absence of B cells. Infect Immun 67 : 266–270.
  5. Huber M, Timms E, Mak TW, Rollinghoff M, Lohoff M, 1998. Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infect Immun 66 : 3968–3970.
  6. Safe SS, 1990. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors. Crit Rev Toxicol 21 : 51–88.
  7. Zook DR, Rappe C, 1994. Environmental sources, distribution, and fate of polychlorinated dibenzodioxins, dibenzofurans, and related organochlorines. Schecter A, ed. Dioxins and Health. New York: Plenum Press.
  8. Birnbaum LS, Tuomisto J, 2000. Non-carcinogenic effects of TCDD in animals. Food Addit Contam 17 : 275–288.
  9. Kerkvliet NI, 1995. Immunological effects of chlorinated dibenzo-p-dioxins. Environ Health Perspect 103 (Suppl 9): 47–53.
  10. Vorderstrasse BA, Steppan LB, Silverstone AE, Kerkvliet NI, 2001. Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol Appl Pharmacol 171 : 157–164.
  11. Jeon MS, Esser C, 2000. The murine IL-2 promoter contains distal regulatory elements reponsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J Immunol 165 : 6975–6983.
  12. Kamath AB, Camacho I, Nagarkatti PS, Nagarkatti M, 1999. Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity. Toxicol Appl Pharmacol 160 : 141–155.
  13. Prell RA, Kerkvliet NI, 1997. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma. J Immunol 158 : 2695–2703.
  14. Kerkvliet NI, Baecher-Steppan L, Shepherd DM, Oughton JA, Vorderstrasse BA, DeKrey GK, 1996. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Immunol 157 : 2310–2319.
  15. Titus RG, Ceredig R, Cerottini JC, Louis JA, 1985. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol 135 : 2108–2114.
  16. Yang DM, Fairweather N, Button LL, McMaster WR, Kahl LP, Liew FY, 1990. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J Immunol 145 : 2281–2285.
  17. Lima HC, Bleyenberg JA, Titus RG, 1997. A simple method for quantifying Leishmania in tissues of infected animals. Parasitol Today 13 : 80–83.
  18. Warren TK, Mitchell KA, Lawrence BP, 2000. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated responses to influenza A virus without affecting cytolytic activity in the lung. Toxicol Sci 56 : 114–123.
  19. Shepherd DM, Dearstyne EA, Kerkvliet NI, 2000. The effects of TCDD on the activation of ovalbumin (OVA)-specific DO11.10 transgenic CD4+ T cells in adoptively transferred mice. Toxicol Sci 56 : 340–350.
  20. Ito T, Inouye K, Fujimaki H, Tohyama C, Nohara K, 2002. Mechanism of TCDD-induced suppression of antibody production: Effect on T cell-derived cytokine production in the primary immune reaction of mice. Toxicol Sci 70 : 46–54.
  21. Chakkalath HR, Titus RG, 1994. Leishmania major-parasitized macrophages augment Th2-type T cell activation. J Immunol 153 : 4378–4387.
  22. Mbow ML, DeKrey GK, Titus RG, 2001. Leishmania major induces differential expression of costimulatory molecules on mouse epidermal cells. Eur J Immunol 31 : 1400–1409.
  23. Alsharif NZ, Schlueter WJ, Stohs SJ, 1994. Stimulation of NADPH-dependent reactive oxygen species formation and DNA damage by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat peritoneal lavage cells. Arch Environ Contam Toxicol 26 : 392.
  24. Alsharif NZ, Lawson T, Stohs SJ, 1994. Oxidative stress induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin is mediated by the aryl hydrocarbon (Ah) receptor complex. Toxicology 92 : 39–51.
  25. Kerkvliet NI, Oughton JA, 1993. Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells. Toxicol Appl Pharmacol 119 : 248–257.
  26. Taylor MJ, Lucier GW, Mahler JF, Thompson M, Lockhart AC, Clark GC, 1992. Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicol Appl Pharmacol 117 : 126–132.
  27. van Grevenynghe J, Sparfel L, Le Vee M, Gilot D, Drenou B, Fauchet R, Fardel O, 2004. Cytochrome P450-dependent toxicity of environmental polycyclic aromatic hydrocarbons towards human macrophages. Biochem Biophys Res Commun 317 : 708–716.
  28. Mantovani A, Vecchi A, Luini W, Sironi M, Candiani GP, Spreafico F, Garattini S, 1980. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on macrophage and natural killer cell mediated cytotoxicity in mice. Biomedicine 32 : 200–204.
  29. Vos JG, Kreeftenberg JG, Engel HWB, Minderhoud A, Van Noorle Jansen LM, 1978. Studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin induced immune suppression and decreased resistance to infection: Endotoxin hypersensitivity, serum zinc concentrations and effect of thymosin treatment. Toxicology 9 : 75–86.
  30. Nacy CA, Meierovies AI, Belosevic M, Green SJ, 1991. Tumor necrosis factor-alpha: Central regulatory cytokine in the induction of macrophage antimicrobial activities. Pathobiology 59 : 182–184.
  31. Kerkvliet NI, Oughton JA, 1993. Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): Phenotypic and functional analysis of peritoneal exudate cells. Toxicol Appl Pharmacol 119 : 248–257.
  32. Taylor MJ, Lucier GW, Mahler JF, Thompson M, Lockhart AC, Clark GC, 1992. Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicol Appl Pharmacol 117 : 126–132.
  33. Sugita-Konishi Y, Kobayashi K, Naito H, Miura K, Suzuki Y, 2003. Effect of lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on the susceptibility to Listeria infection. Biosci Biotechnol Biochem 67 : 89–93.
  34. Tucker AN, Vore SJ, Luster MI, 1986. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol 29 : 372–377.
  35. Hahn ME, 2002. Aryl hydrocarbon receptors: Diversity and evolution. Chem Biol Interact 141 : 131–160.
  36. Birnbaum LS, 1986. Distribution and excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin in congenic strains of mice which differ at the Ah locus. Drug Metab Dispos 14 : 34–40.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2006.75.749
Loading
/content/journals/10.4269/ajtmh.2006.75.749
Loading

Data & Media loading...

  • Received : 04 Oct 2005
  • Accepted : 24 May 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error